Advanced Proteome Therapeutics, Wilex deal

Advanced Proteome and Wilex’s Heidelberg Pharma GmbH subsidiary partnered to create antibody-drug conjugates (ADCs) to treat cancer. Heidelberg will contribute its Antibody Targeted Amanitin Conjugate...